Diagnosis of Prion Disease: Conventional Approaches

• Abu-Rumeileh S, Baiardi S, Polischi B, et al. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC. J Neurol. 2019;266:3136–43.

  Article  CAS  Google Scholar 

• Abu-Rumeileh S, Baiardi S, Ladogana A, et al. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease. J Neurol Neurosurg Psychiatry. 2020a;91:1181–8. Published online ahead of print, 2020 Sep 14

  Article  Google Scholar 

• Alberti C, Gonzalez J, Maldonado H, Medina F, Barriga A, Garcia L, Kettlun A, Collados L, Puente J, Cartier L, Valenzuela M. Comparative study of CSF neurofilaments in HTLV- 1-associated myelopathy/tropical spastic paraparesis and other neurological disorders. AIDS Res Hum Retroviruses. 2009;25:803–9.

  Article  CAS  Google Scholar 

• Albrecht D, Garcia L, Cartier L, Kettlun AM, Vergara C, Collados L, Valenzuela MA. Trophic factors in cerebrospinal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease. AIDS Res Hum Retroviruses. 2006;22:248��54.

  Article  CAS  Google Scholar 

• Alvarez FJ, Bisbe J, Bisbe V, Dávalos A. Magnetic resonance imaging findings in pre-clinical Creutzfeldt-Jakob disease. Int J Neurosci. 2005;115(8):1219–25.

  Article  CAS  Google Scholar 

• Anuja P, Venugopalan V, Darakhshan N, et al. Rapidly progressive dementia: An eight year (2008–2016) retrospective study. PLoS One. 2018; [cited 2018 Jul 5];[13 p]

  Google Scholar 

• Arruda WO, Bordignon KC, Milano JB, Ramina R. Creutzfeldt-Jakob disease, Heidenhain variant: case report with MRI (DWI) findings. Arq Neuropsiquiatr. 2004;2004(62):347–52.

  Article  Google Scholar 

• Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17:175–8.

  Article  CAS  Google Scholar 

• Bizzi A, Pascuzzo R, Blevins J, et al. Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging. JAMA Neurol. 2020;

  Google Scholar 

• Bizzi A, Pascuzzo R, Blevins J, et al. Subtype diagnosis of sporadic Creutzfeldt-Jakob disease with diffusion magnetic resonance imaging. Ann Neurol. 2021;89(3):560–72.

  Article  CAS  Google Scholar 

• Blennow K, Diaz-Lucena D, Zetterberg H, et al. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD. J Neurol Neurosurg Psychiatry. 2019;90:846–53.

  Article  Google Scholar 

• Bongianni M, Orrú C, Groveman BR, et al. Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples. JAMA Neurol. 2017;74:155–62.

  Article  Google Scholar 

• Carswell C, Thompson A, Lukic A, Stevens J, Rudge P, Mead S, Collinge J, Hyare H. MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC Neurol. 2012;12:153.

  Article  Google Scholar 

• Cartier L, Garcia L, Kettlun AM, Castaneda P, Collados L, Vasquez F, Giraudon P, Belin MF, Valenzuela MA. Extracellular matrix protein expression in cerebrospinal fluid from patients with tropical spastic paraparesis associated with HTLV-I and Creutzfeldt-Jakob dis- ease. Scand J Clin Lab Invest. 2004;2004(64):101–7.

  Article  Google Scholar 

• Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, Capellari S, Pastore M, Rahbar MH, Chen SG, Gambetti P. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology. 2004;63:436–42.

  Article  CAS  Google Scholar 

• Chitravas N, Jung RS, Kofskey DM, Blevins JE, Gambetti P, Leigh RJ, Cohen ML. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol. 2011;70:437–44.

  Article  Google Scholar 

• Choe LH, Green A, Knight RS, Thompson EJ, Lee KH. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from antemortem sporadic Creutzfeldt-Jakob disease. Electrophoresis. 2002;23:2242–6.

  Article  CAS  Google Scholar 

• Choi BY, Kim SY, Seo SY, An SS, Kim S, Park SE, Lee SH, Choi YJ, Kim SJ, Kim CK, Park JS, Ju YR. Mutations at codons 178, 200–129, and 232 contributed to the inherited prion diseases in Korean patients. BMC Infect Dis. 2009;9:132.

  Article  Google Scholar 

• Cohen OS, Chapman J, Korczyn AD, Nitsan Z, Appel S, Hoffmann C, Rosenmann H, Kahana E, Lee H. Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD. J Neurol. 2015;262(3):604–13.

  Article  CAS  Google Scholar 

• Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M, Knight R, Will R. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol. 2003;24:1560–9.

  Google Scholar 

• Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretzschmar HA, Jansen GH, Olsen E, Mitrova E, Alpérovitsch A, Brandel JP, Mackenzie J, Murray K, Will RGRG. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006;129:2278–87.

  Article  CAS  Google Scholar 

• Cramm M, Schmitz M, Karch A, et al. Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol. 2016;53:1896–904.

  Article  CAS  Google Scholar 

• Demaerel P, Heiner L, Robberecht W, Sciot R, Wilms G. Diffusion-weighted MRI in spo- radic Creutzfeldt-Jakob disease. Neurology. 1999;52:205–8.

  Article  CAS  Google Scholar 

• Diaz-Lucena D, Kruse N, Thüne K, Schmitz M, Villar-Piqué A, da Cunha JEG, Hermann P, López-Pérez Ó, Andrés-Benito P, Ladogana A, Calero M, Vidal E, Riggert J, Pineau H, Sim V, Zetterberg H, Blennow K, Del Río JA, Marín-Moreno A, Espinosa JC, Torres JM, Sánchez-Valle R, Mollenhauer B, Ferrer I, Zerr I, Llorens F. TREM2 expression in the brain and biological fluids in prion diseases. Acta Neuropathol. 2021;141(6):841–59.

  Article  CAS  Google Scholar 

• Dorey A, Tholance Y, Vighetto A, et al. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. JAMA Neurol. 2015;72:267–75.

  Article  Google Scholar 

• Eisenmenger L, Porter MC, Carswell CJ, et al. Evolution of diffusion-weighted magnetic resonance imaging signal abnormality in sporadic Creutzfeldt-Jakob disease, with histopathological correlation. JAMA Neurol. 2016;73(1):76–84.

  Article  Google Scholar 

• Ermann N, Lewczuk P, Schmitz M, et al. CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD. Ann Clin Transl Neurol. 2018;5:883–7.

  Article  CAS  Google Scholar 

• Finkenstaedt M, Szudra A, Zerr I, Poser S, Hise JH, Stoebner JM, Weber T. MR imaging of Creutzfeldt-Jakob disease. Radiology. 1996;199:793–8.

  Article  CAS  Google Scholar 

• Fiorini M, Iselle G, Perra D, et al. High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD. Int J Mol Sci. 2020;21:pii: E880.

  Article  Google Scholar 

• Foutz A, Appleby BS, Hamlin C, et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann Neurol. 2017;81:79–92.

  Article  CAS  Google Scholar 

• Franceschini A, Baiardi S, Hughson AG, McKenzie N, Moda F, Rossi M, Capellari S, Green A, Giaccone G, Caughey B, Parchi P. High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci Rep. 2017;7(1):10655.

  Article  Google Scholar 

• Fulbright RK, Kingsley PB, Guo X, Hoffmann C, Kahana E, Chapman JC, Prohovnik I. The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation. Magn Reson Imaging. 2006;24:1121–9.

  Article  CAS  Google Scholar 

• Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I. MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol. 2008;29:1638–43.

  Article  CAS  Google Scholar 

• Gaig C, Valldeoriola F, Gelpi E, Ezquerra M, Llufriu S, Buongiorno M, Rey MJ, Marti MJ, Graus F, Tolosa E. Rapidly progressive diffuse Lewy body disease. Mov Disord. 2011;26:1316–23.

  Article  Google Scholar 

• Gao LP, Shi Q, Xiao K, et al. The genetic Creutzfeldt-Jakob disease with E200K mutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients. Sci Rep. 2019;9(1):1836. Published 2019 Feb 12

  Article  Google Scholar 

• Gawinecka J, Ciesielczyk B, Sanchez-Juan P, Schmitz M, Heinemann U, Zerr I. Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt–Jakob disease differential diagnosis. Neurodegener Dis. 2012;9:139–44.

  Article  CAS  Google Scholar 

• Gmitterová K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I. 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular sub- types. Neurobiol Aging. 2009;30(11):1842–50.

  Article  Google Scholar 

• Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, Ironside JW, Will RG, Knight RS. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001;70(6):744–8.

  Article  CAS  Google Scholar 

• Green AJ, Ramljak S, Muller WE, Knight RS, Schroder HC. 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein. Neurosci Lett. 2002;24:57–60.

  Article  Google Scholar 

• Green A, Sanchez-Juan P, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Heinemann U, Hess K, Slivarichova D, Saiz A, Calero M, Mellina V, Knight R, van Dujin CM, Zerr I. CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol. 2007;14:121–4.

  Article  CAS  Google Scholar 

• Groveman BR, Orrú CD, Hughson AG, et al. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann Clin Transl Neurol. 2017;4:139–44.

  Article  CAS  Google Scholar 

• Guillaume E, Zimmermann C, Burkhard PR, Hochstrasser DF, Sanchez JC. A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics. 2003;3:1495–9.

  Article  CAS  Google Scholar 

• Halbgebauer S, Abu-Rumeileh S, Oeckl P, Steinacker P, Roselli F, Wiesner D, Mammana A, Beekes M, Kortazar-Zubizarreta I, Perez de Nanclares G, Capellari S, Giese A, Castilla J, Ludolph AC, Žáková D, Parchi P, Otto M. Blood β-synuclein and neurofilament light chain during the course of prion disease. Neurology. 2022;98(14):e1434–45.

  Article  CAS  Google Scholar 

• Harrington MG, Merril CR, Asher DM, Gajdusek DC. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med. 1986;315:279–83.

  Article  CAS  Google Scholar 

• Heinemann U, Krasnianski A, Meissner B, Gloeckner SF, Kretzschmar HA, Zerr I. Molecular subtype-specific clinical diagnosis of prion diseases. Vet Microbiol. 2007a;123:328–35.

  Article  CAS  Google Scholar 

• Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007b;130(Pt 5):1350–9.

  Article  CAS  Google Scholar 

• Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;91:e331–8.

  Article  Google Scholar 

• Hermann P, Koch JC, Zerr I. Genetic prion disease: opportunities for early therapeutic intervention with rigorous pre-symptomatic trials. Expert Opin Investig Drugs. 2020;29(12):1313–6.

  Article  CAS  Google Scholar 

• Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwind MD, Green A, Haïk S, Kovacs GG, Ladogana A, Llorens F, Mead S, Nishida N, Pal S, Parchi P, Pocchiari M, Satoh K, Zanusso G, Zerr I. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20(3):235–46.

  Article  CAS  Google Scholar 

• Hermann P, Haller P, Goebel S, Bunck T, Schmidt C, Wiltfang J, Zerr I. Total and phosphorylated cerebrospinal fluid tau in the differential diagnosis of sporadic Creutzfeldt-Jakob disease and rapidly progressive Alzheimer’s disease. Viruses. 2022;14(2):276.

  Article  Google Scholar 

• Holsinger RM, Lee JS, Boyd A, Masters CL, Collins SJ. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias. Neurology. 2006;67:710–2.

  Article  CAS  Google Scholar 

• Hsich G, Kenney K, Gibbs CJ Jr, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongifrom encephalopathies. N Engl J Med. 1996;335:924–30.

  Article  CAS  Google Scholar 

• Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, Lehnert S, Kretzschmar HA, Baier M, Otto M. Glial fibrillary acidic protein and protein S-100B: different concentration pat- tern of glial proteins in cerebrospinal fluid of patients with Alzheimer’s disease and Creutzfeldt- Jakob disease. J Alzheimers Dis. 2009;17:541–51.

  Article  CAS  Google Scholar 

• Josephs KA, Ahlskog JE, Parisi JE, Boeve BF, Crum BA, Giannini C, Petersen RC. Rapidly progressive neurodegenerative dementias. Arch Neurol. 2009;66:201–7.

  Article  Google Scholar 

• Kasai T, Tokuda T, Ishii R, Ishigami N, Tsuboi Y, Nakagawa M, Mizuno T, El-Agnaf OM. Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol. 2014;261(6):1203–9.

  Article  CAS  Google Scholar 

• Kelley BJ, Boeve BF, Josephs KA. Young-onset dementia: demographic and etiologic char- acteristics of 235 patients. Arch Neurol. 2008;65:1502–8.

  Article  Google Scholar 

• Kettlun A, Collados L, Garcia L, Cartier LA, Wolf ME, Mosnaim AD, Valenzuela MA. Matrix metalloproteinase profile in patients with Creuztfeldt-Jakob disease. Int J Clin Pract. 2003;57:475–8.

  CAS  Google Scholar 

• Koizumi R, Ueda N, Mugita A, Kimura K, Kishida H, Tanaka F. Case report: Extremely early detection of preclinical magnetic resonance imaging abnormality in Creutzfeldt-Jakob disease with the V180I mutation. Front Neurol. 2021;12:751750.

  Article  Google Scholar 

• Kovacs GG, Andreasson U, Liman V, et al. Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort. Eur J Neurol. 2017;24:1326–e77.

  Article  CAS  Google Scholar 

• Kovacs GG, Andreasson U, Liman V, Regelsberger G, Lutz MI, Danics K, Keller E, Zetterberg H, Blennow K. Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort. Eur J Neurol. 2017c;24(11):1326–e77.

  Article  CAS  Google Scholar 

• Krammer C, Vorberg I, Schätzl HM, Gilch S. Therapy in prion diseases: from molecular and cellular biology to therapeutic targets. Infect Disord Drug Targets. 2009;9:3–14.

  Article  CAS  Google Scholar 

• Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, Meissner B, Collie DA, Roeber S, Bartl M, Heinemann U, Varges D, Kretzschmar HA, Zerr I. Clinical findings and diagnostic tests in the MV-2 subtype of sporadic CJD. Brain. 2006;129:2288–96.

  Article  Google Scholar 

• Krasnianski A, Heinemann U, Ponto C, Kortt J, Kallenberg K, Varges D, Schulz-Schaeffer WJ, Kretzschmar HA, Zerr I. Clinical findings and diagnosis in genetic prion diseases in Germany. Eur J Epidemiol. 2016;31(2):187–96.

  Article  CAS  Google Scholar 

• Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel J-P, Poser S, Kretzschmar H, Rietveld I, Mitrova E, de Pedro-Cuesta J, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64:1586–91.

  Article  CAS  Google Scholar 

• Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol. 2009;256:1620–8.

  Article  CAS  Google Scholar 

• Lattanzio F, Abu-Rumeileh S, Franceschini A, et al. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. Acta Neuropathol. 2017;133:559–78.

  Article  CAS  Google Scholar 

• Lee H, Rosenmann H, Chapman J, Kingsley PB, Hoffmann C, Cohen OS, Kahana E, Korczyn AD, Prohovnik I. Thalamo-striatal diffusion reductions precede disease onset in prion muta- tion carriers. Brain. 2009;132:2680–7.

  Article  Google Scholar 

• Lee H, Cohen OS, Hoffmann C, Prohovnik I. Putaminal volume and diffusion in early familial Creutzfeldt-Jakob disease. J Neurol Sci. 2010;288:129–34.

  Article  Google Scholar 

• Leitão MJ, Baldeiras I, Almeida MR, et al. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay. Neuroscience. 2016;322:398–407.

  Article  Google Scholar 

• Li J, Duan Y, Zhao D, et al. Detection of Cell-Free Mitochondrial DNA in Cerebrospinal Fluid of Creutzfeldt-Jakob Patients. Front Neurol. 2019;10:645.

  Article  Google Scholar 

• Llorens F, Thüne K, Tahir W, et al. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Mol Neurodegener. 2017;12:83.

  Article  Google Scholar 

• Llorens F, Villar-Piqué A, Hermann P, et al. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3. J Neurol. 2020a;267:543–50.

  Article  CAS  Google Scholar 

• Llorens F, Villar-Piqué A, Hermann P, Schmitz M, Calero O, Stehmann C, Sarros S, Moda F, Ferrer I, Poleggi A, Pocchiari M, Catania M, Klotz S, O’Regan C, Brett F, Heffernan J, Ladogana A, Collins SJ, Calero M, Kovacs GG, Zerr I. Diagnostic accuracy of prion disease biomarkers in Iatrogenic Creutzfeldt-Jakob disease. Biomolecules. 2020b;10(2):290.

  Article  CAS  Google Scholar 

• Llorens F, Villar-Piqué A, Schmitz M, et al. Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases. Neuropathol Appl Neurobiol. 2020c;46:240–54.

  Article  CAS  Google Scholar 

• López-Pérez Ó, Bernal-Martín M, Hernaiz A, et al. BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers. Biomolecules. 2020;10:706.

  Article  Google Scholar 

• Maat P, de Beukelaar JW, Jansen C, Schuur M, van Duijn CM, van Coevorden MH, et al. Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease. Neurol Neuroimmunol Neuroinflamm. 2015;2:e178.

  Article  Google Scholar 

• Mammana A, Baiardi S, Rossi M, et al. Detection of prions in skin punch biopsies of Creutzfeldt-Jakob disease patients. Ann Clin Transl Neurol. 2020;7:559–64.

  Article  CAS  Google Scholar 

• Manaka H, Kato T, Kurita K, Katagiri T, Shikama Y, Kujirai K, Kawanami T, Suzuki Y, Nihei K, Sasaki H, et al. Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease. Neurosci Lett. 1992;139:47–9.

  Article  CAS  Google Scholar 

• Marquetand J, Knake S, Strzelczyk A, et al. Periodic EEG patterns in sporadic Creutzfeld-Jakob-Disease can be benzodiazepine-responsive and be difficult to distinguish from non-convulsive status epilepticus. Seizure. 2017;53:47–50.

  Article  Google Scholar 

• Masters CL, Harris JO, Gajdusek DC, Gibbs CJJ, Bernoulli C, Asher DM. Creutzfeldt- Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979;5:177–88.

  Article  CAS  Google Scholar 

• McGuire LI, Peden AH, Orrú CD, et al. RT-QuIC analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2012;72:278–85.

  Article  Google Scholar 

• Meissner B, Kallenberg K, Sanchez-Juan P, Krasnianski A, Heinemann U, Varges D, Knauth M, Zerr I. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. Am J Neuroradiol. 2008;29:1519–24.

  Article  CAS  Google Scholar 

• Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S, Collins SJ, Smith P, Cras P, Jansen GH, Brandel JP, Coulthart MB, Roberts H, Van Everbroeck B, Galanaud D, Mellina V, Will RG, Zerr I. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology. 2009;72(23):1994–2001.

  Article  CAS  Google Scholar 

• Minghetti L, Cardone F, Greco A, Puopolo M, Levi G, Green AJ, Knight R, Pocchiari P. Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease. Neurology. 2002;58:127–9.

  Article  CAS  Google Scholar 

• Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012;79:1499–506.

  Article  CAS  Google Scholar 

• Norsworthy PJ, Thompson AGB, Mok TH, et al. A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis. Nat Commun. 2020;11:3960.

  Article  CAS  Google Scholar 

• Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Kuzuhara S, Inuzuka T, Takeda M, Kuroda S, Abe K, Murai H, Murayama S, Tateishi J, Takumi I, Shirabe S, Harada M, Sadakane A, Yamada M. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133(10):3043–57.

  Article  Google Scholar 

• Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto Novi G, Canosa A, Nobili F, et al. Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease. Eur J Neurol. 2018;25(12):e127–8.

  Article  Google Scholar 

• Oeckl P, Steinacker P, Lehnert S, Jesse S, Kretzschmar HA, Ludolph AC, Otto M, Ferger B. CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson’s disease and amyotrophic lateral sclerosis. PLoS One. 2012;7(3):e32664.

  Article  CAS  Google Scholar 

• Oeckl P, Metzger F, Nagl M, et al. Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer’s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies. Mol Cell Proteomics. 2016;15:3126–38.

  Article  CAS  Google Scholar 

• Oeckl P, Halbgebauer S, Anderl-Straub S, et al. Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer’s Disease. J Proteome Res. 2020;19:1310–8.

  Article  CAS  Google Scholar 

• Orrú CD, Bongianni M, Tonoli G, et al. A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med. 2014;371:519–29.

  Article  Google Scholar 

• Orrú CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio. 2015;6:e02451–14.

  Article  Google Scholar 

• Otto M, Wiltfang J, Schütz E, Zerr I, Otto A, Pfahlberg A, Gefeller O, Uhr M, Giese A, Weber T, Kretzschmar HA, Poser S. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ. 1998;316(7131):577–82.

  Article  CAS  Google Scholar 

• Papageorgiou SG, Kontaxis T, Bonakis A, et al. Rapidly progressive dementia: Causes found in a Greek tertiary referral center in Athens. Alzheimer Dis Assoc Disord. 2009;23:337–46.

  Article  Google Scholar 

• Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowski JQ, Petersen RB, Gambetti P. Molecular basis of phenotypic vari- ability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996;39:767–78.

  Article  CAS  Google Scholar 

• Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–33.

  Article  CAS  Google Scholar 

• Park JH, Choi YG, Lee YJ, et al. Real-Time Quaking-Induced Conversion Analysis for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease in Korea. J Clin Neurol. 2016;12:101–6.

  Article  Google Scholar 

• Pascuzzo R, Oxtoby NP, Young AL, et al. Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 2020;140:169–81.

  Article  Google Scholar 

• Piubelli C, Fiorini M, Zanusso G, Milli A, Fasoli E, Monaco S, Righetti PG. Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping. Proteomics. 2006;6(Suppl 1):256–61.

  Article  Google Scholar 

• Rhoads DD, Wrona A, Foutz A, Blevins J, Glisic K, Person M, Maddox RA, Belay ED, Schonberger LB, Tatsuoka C, Cohen ML, Appleby BS. Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology. 2020;95(8):e1017–26.

  Article  CAS  Google Scholar 

• Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O, Gabizon R. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology. 1997;49:593–5.

  Article  CAS  Google Scholar 

• Rudge P, Hyare H, Green A, Collinge J, Mead S. Imaging and CSF analyses effectively distinguish CJD from its mimics. J Neurol Neurosurg Psychiatry. 2018;89:461–6.

  Article  Google Scholar 

• Sanchez JC, Guillaume E, Lescuyer P, Allard L, Carrette O, Scherl A, Burgess J, Corthals GL, Burkhard PR, Hochstrasser DF. Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics. 2004;4:2229–33.

  Article  CAS  Google Scholar 

• Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens C, Van Duijn C, Zerr I. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006;67:637–43.

  Article  CAS  Google Scholar 

• Sanchez-Juan P, Sanchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichova D, Saiz A, Calero M, Pocchiari M, Knight R, van Dujin CM, Zerr I. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol. 2007;254:901–6.

  Article  CAS  Google Scholar 

• Schmidt H, Otto M, Niedmann P, Cepek L, Schroter A, Kretzschmar HA, Poser S. CSF lactate dehydrogenase activity in patients with Creutzfeldt-Jakob disease exceeds that in other dementias. Dement Geriatr Cogn Disord. 2004;17:204–6.

  Article  CAS  Google Scholar 

• Schmidt C, Redyk K, Meissner B, Krack L, von Ahsen N, Roeber S, Kretzschmar H, Zerr I. Clinical features of rapidly progressive Alzheimer’s disease. Dement Geriatr Cogn Disord. 2010;29:371–8.

  Article  CAS  Google Scholar 

• Schmitz M, Ebert E, Stoeck K, et al. Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic. Mol Neurobiol. 2016a;53:2189–99.

  Article  CAS  Google Scholar 

• Schmitz M, Llorens F, Pracht A, et al. Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients. Aging (Albany NY). 2016b;8:2927–35.

  Article  CAS  Google Scholar 

• Schmitz M, Villar-Piqué A, Hermann P, Escaramís G, Calero M, Chen C, Kruse N, Cramm M, Golanska E, Sikorska B, Liberski PP, Pocchiari M, Lange P, Stehmann C, Sarros S, Martí E, Baldeiras I, Santana I, Žáková D, Mitrová E, Dong XP, Collins S, Poleggi A, Ladogana A, Mollenhauer B, Kovacs GG, Geschwind MD, Sánchez-Valle R, Zerr I, Llorens F. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases. Brain. 2022;145(2):700–12.

  Article  Google Scholar 

• Schröter A, Zerr I, Henkel K, Tschampa HJ, Finkenstaedt M, Poser S. Magnetic resonance imaging (MRI) in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol. 2000;57:1751–7.

  Article  Google Scholar 

• Seror I, Lee H, Cohen OS, Hoffmann C, Prohovnik I. Putaminal volume and diffusion in early familial Creutzfeldt-Jakob disease. J Neurol Sci. 2010;288:129–34.

  Article  Google Scholar 

• Silveyra MX, Garcia-Ayllon MS, Calero M, Saez-Valero J. Altered glycosylation of acetyl- cholinesterase in the Creutzfeldt-Jakob cerebrospinal fluid. J Mol Neurosci. 2006;30:65–6.

  Article  CAS  Google Scholar 

• Singh A, Beveridge AJ, Singh N. Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders. PLoS One. 2011;6(3):e16804.

  Article  CAS  Google Scholar 

• Skillbäck T, Rosén C, Asztely F, Mattsson N, Blennow K, Zetterberg H. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry. JAMA Neurol. 2014;71:476–83.

  Article  Google Scholar 

• Steinacker P, Blennow K, Halbgebauer S, et al. Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease. Sci Rep. 2016;6:38737.

  Article  CAS  Google Scholar 

• Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004;56:702–8.

  Article  Google Scholar 

• Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130:1350–9.

  Article  Google Scholar 

• Stoeck K, Bodemer M, Ciesielczyk B, Meissner B, Bartl M, Heinemann U, Zerr I. Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt- Jakob disease. Arch Neurol. 2005;62:1591–4.

  Article  Google Scholar 

• Stoeck K, Bodemer M, Zerr I. Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol. 2006;172:175–81.

  Article  CAS  Google Scholar 

• Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc’h K, Schelzke G, Karch A, van Duijn CM, Zerr I. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain. 2012;135(Pt 10):3051–61.

  Article  Google Scholar 

• Studart Neto A, Soares Neto HR, Simabukuro MM, et al. Rapidly progressive dementia: prevalence and causes in a neurologic unit of a tertiary hospital in Brazil. Alzheimer Dis Assoc Disord. 2017;31:239–43.

  Article  Google Scholar 

• Thompson AGB, Luk C, Heslegrave AJ, et al. Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression. J Neurol Neurosurg Psychiatry. 2018;89:955–61.

  Article  Google Scholar 

• Thompson AGB, Anastasiadis P, Druyeh R, et al. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Mol Psychiatry. 2021;26(10):5955–66.

  Article  CAS  Google Scholar 

• Tribl GG, Strasser G, Zeitlhofer J, Asenbaum S, Jarius C, Wessely P, Prayer D. Sequential MRI in a case of Creutzfeld-Jakob disease. Neuroradiology. 2002;44:223–6.

  Article  CAS  Google Scholar 

• Tschampa HJ, Kallenberg K, Urbach H, Meissner BCN, Kretzschmar HA, Knauth M, Zerr I. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agree- ment. Brain. 2005;128:2026–33.

  Article  Google Scholar 

• Tsuboi Y, Baba Y, Doh-ura K, Imamura A, Fujioka S, Yamada T. Diffusion-weighted MRI in familial Creutzfeldt-Jakob disease with the codon 200 mutation in the prion protein gene. J Neurol Sci. 2005;232:45–9.

  Article  CAS  Google Scholar 

• Ukisu R, Kushihashi T, Kitanosono T, et al. Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. AJR Am J Roentgenol. 2005;184:560–6.

  Article  Google Scholar 

• Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology. 1998;40:65–70.

  Article  CAS  Google Scholar 

• Vallabh SM, Minikel EV, Schreiber SL, Lander ES. Towards a treatment for genetic prion disease: trials and biomarkers. Lancet Neurol. 2020;19:361–8.

  Article  CAS  Google Scholar 

• Van Everbroeck B, Quoilin S, Boons J, Martin JJ, Cras P. A prospective study of CSF mark- ers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2003;74:1210–4.

  Article  Google Scholar 

• Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin J-J, Cras P. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol. 2004;251:298–304.

  Article  Google Scholar 

• Villar-Piqué A, Schmitz M, Lachmann I, Karch A, Calero O, Stehmann C, Sarros S, Ladogana A, Poleggi A, Santana I, Ferrer I, Mitrova E, Žáková D, Pocchiari M, Baldeiras I, Calero M, Collins SJ, Geschwind MD, Sánchez-Valle R, Zerr I, Llorens F. Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.Mol Neurobiol. 2019 Apr;56(4):2811-2821.

  Google Scholar 

• Villar-Piqué A, Schmitz M, Hermann P, et al. Plasma YKL-40 in the spectrum of neurodegenerative dementia. J Neuroinflammation. 2019;16:145.

  Article  Google Scholar 

• Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76:1711–9.

  Article  CAS  Google Scholar 

• Völkel D, Zimmermann K, Zerr I, Bodemer M, Lindner T, Turecek PL, Poser S, Schwarz HP. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion. 2001;41:441–8.

  Article  Google Scholar 

• Watson N, Hermann P, Ladogana A, Denouel A, Baiardi S, Colaizzo E, Giaccone G, Glatzel M, Green AJE, Haïk S, Imperiale D, MacKenzie J, Moda F, Smith C, Summers D, Tiple D, Vaianella L, Zanusso G, Pocchiari M, Zerr I, Parchi P, Brandel JP, Pal S. Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for Sporadic Creutzfeldt-Jakob Disease. JAMA Netw Open. 2022;5(1):e2146319.

  Article  Google Scholar 

• WHO. WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. WHO Library Cataloguing-in-Publication Data; 2003.

  Google Scholar 

• Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, Mackenzie J, Estibeiro K, Green AJ, Knight RS. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. 2000;47:575–82.

  Article  CAS  Google Scholar 

• Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol. 2005;26:1551–62.

  Google Scholar 

• Zanusso G, Camporese G, Ferrari S, et al. Long-term preclinical magnetic resonance imaging alterations in sporadic Creutzfeldt–Jakob disease. Ann Neurol. 2016;80:629–32.

  Article  Google Scholar 

• Zerr I. Laboratory diagnosis of Creutzfeldt-Jakob disease. N Engl J Med. 2022;386:1345–50.

  Article  CAS  Google Scholar 

• Zerr I, Hermann P. Diagnostic challenges in rapidly progressive dementia. Expert Rev Neurother. 2018;18(10):761–72.

  Article  CAS  Google Scholar 

• Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998a;43:32–40.

  Article  CAS  Google Scholar 

• Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro CJ, Knight RSG, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Fletcher A, Bodemer M, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55:811–5.

  Article  CAS  Google Scholar 

• Zerr I, Bodemer M, Kaboth U, Kretzschmar H, Oellerich M, Armstrong VW. Plasminogen activities and concentrations in patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett. 2004;371:163–6.

  Article  CAS  Google Scholar 

• Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie DA, Smith P, Varges D, Heinemann U, Meissner B, Roberts H, Brandel JP, Van Dujin CM, Pocchiari M, Begue P, Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt- Jakob disease. Brain. 2009;132:2659–68.

  Article  CAS  Google Scholar 

• Zerr I, Villar-Piqué A, Hermann P, et al. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease. Alzheimers Res Ther. 2021;13(1):86. Published 2021 Apr 21

  Article  CAS  Google Scholar 

• Zhang Y, Gao T, Tao QQ. Spectrum of noncerebrovascular rapidly progressive cognitive deterioration: a 2-year retrospective study. Clin Interv Aging. 2017;12:1655–9.

  Article  Google Scholar 

Download references